Hudson Bay Capital Management
IMUX icon

Hudson Bay Capital Management’s Immunic IMUX Stock Holding History

Hudson Bay Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,302
Closed -$236K – 1510
2026
Q1 		$236K Buy
+21,302
New +$191K ﹤0.01% 1076
2025
Q2 		– Sell
-1,457
Closed -$15.9K – 1509
2025
Q1 		$15.9K Buy
+1,457
New +$15.7K ﹤0.01% 1236
2020
Q3 		– Sell
-12,305
Closed -$1.49M – 595
2020
Q2 		$1.49M Buy
+12,305
New +$1.25M 0.03% 341

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Hudson Bay Capital Management's IMUX Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Immunic (IMUX) in Q2 2026, closing a stake of 21,302 shares — an estimated $236K sold.

Hudson Bay Capital Management first reported a position in IMUX in Q2 2020 and held it in 3 quarters. The position peaked at $1.49M in Q2 2020. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 21,302 Immunic shares in Q2 2026, an estimated $236K.
  • Hudson Bay Capital Management first reported a position in Immunic in Q2 2020 and held it in 3 quarters.
  • Hudson Bay Capital Management's Immunic position peaked at $1.49M in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.